Literature DB >> 2357088

Idiopathic thrombocytopenic purpura: predictors of chronic disease.

L G Robb1, K Tiedeman.   

Abstract

We studied the extent to which patient characteristics influenced outcome in childhood idiopathic thrombocytopenic purpura in a historical cohort of 289 children over a 20 year period (1968-87). Outcome was classified as acute or chronic depending on whether the platelet count had returned to normal (150 X 10(9)/l) by six months after diagnosis. Fifty three cases (18%) had chronic idiopathic thrombocytopenic purpura. The likelihood of chronic disease was determined by logistic regression analysis of five patient variables: age, sex, season of onset of symptoms, history of recent viral illness, and duration of symptoms at presentation. A history of symptoms of greater than 14 days at presentation, adjusted for the other variables, was strongly predictive of chronic idiopathic thrombocytopenic purpura; the other variables did not significantly affect outcome. At 28 days after diagnosis 138 (47%) of the study cohort had normal platelet counts. Children whose platelet counts were less than 150 X 10(9)/l had a threefold risk of progressing to chronic idiopathic thrombocytopenic purpura, which increased to fivefold if counts were less than 50 X 10(9)/l. Two thirds of patients in the chronic group, irrespective of treatment, remained thrombocytopenic two years after diagnosis. We conclude that a history of symptoms for greater than two weeks at presentation is strongly predictive of chronic idiopathic thrombocytopenic purpura. If platelet counts are subnormal 28 days after diagnosis the risk of chronic idiopathic thrombocytopenic purpura is increased with prolonged thrombocytopenia being very likely if platelet counts remain low three months after diagnosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357088      PMCID: PMC1792171          DOI: 10.1136/adc.65.5.502

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Idiopathic thrombocytopenic purpura in childhood.

Authors:  J H WALKER; W WALKER
Journal:  Arch Dis Child       Date:  1961-12       Impact factor: 3.791

2.  Idiopathic thrombocytopenic purpura in children: results of steroid therapy and splenectomy.

Authors:  E S Beham; L I Taft
Journal:  Aust Paediatr J       Date:  1972-12

Review 3.  Therapeutic considerations in childhood idiopathic thrombocytopenic purpura.

Authors:  R Ware; T R Kinney
Journal:  Crit Rev Oncol Hematol       Date:  1987       Impact factor: 6.312

4.  The need for randomization in the study of intended effects.

Authors:  O S Miettinen
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

Review 5.  Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias.

Authors:  J M Lusher; I Warrier
Journal:  Am J Med       Date:  1987-10-23       Impact factor: 4.965

6.  Idiopathic thrombocytopenic purpura in childhood.

Authors:  J M Lusher; W W Zuelzer
Journal:  J Pediatr       Date:  1966-06       Impact factor: 4.406

Review 7.  Idiopathic thrombocytopenic purpura in children.

Authors:  J M Lusher; R Iyer
Journal:  Semin Thromb Hemost       Date:  1977-01       Impact factor: 4.180

8.  Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura.

Authors:  S J Woerner; C F Abildgaard; B N French
Journal:  Pediatrics       Date:  1981-04       Impact factor: 7.124

Review 9.  The nontreatment of childhood idiopathic thrombocytopenic purpura.

Authors:  G R Buchanan
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

10.  Alternatives to splenectomy in the management of chronic idiopathic thrombocytopenic purpura in childhood.

Authors:  E C Russell; H M Maurer
Journal:  Am J Pediatr Hematol Oncol       Date:  1984
View more
  8 in total

1.  Serum immunoglobulin levels at onset: association with the prognosis of childhood idiopathic thrombocytopenic purpura.

Authors:  Masaru Kubota; Ikuya Usami; Ken-ichiro Kobayashi; Tsutomu Tsutsui; Kousaku Matsubara
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

2.  Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.

Authors:  O B Eden; J S Lilleyman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

Review 3.  Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology.

Authors:  J S Lilleyman
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

4.  Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Authors:  Masaru Kubota; Souichi Adachi; Ikuya Usami; Masayuki Okada; Toshiyuki Kitoh; Mitsutaka Shiota; Yoshihiro Taniguchi; Akihiko Tanizawa; Mitsuhiko Nanbu; Keigo Hamahata; Hisanori Fujino; Kousaku Matsubara; Yoshihiro Wakazono; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

5.  Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Josefina Aparecida Pellegrini Braga; Sandra Regina Loggetto; Andrea Thives de Carvalho Hoepers; Wanderley Marques Bernardo; Leticia Medeiros; Mônica Pinheiro de Almeida Veríssimo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

6.  Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis.

Authors:  Alexandros Makis; Athanasios Gkoutsias; Theodoros Palianopoulos; Eleni Pappa; Evangelia Papapetrou; Christina Tsaousi; Eleftheria Hatzimichael; Nikolaos Chaliasos
Journal:  Adv Hematol       Date:  2017-12-06

7.  Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.

Authors:  Tao Li; Gui-Ling Yan; Zhu Luo; Qi Xie; Mei-Mei Lai; Zhan-Guo Chen; Xiao-Qun Zheng
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

8.  High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.

Authors:  Chae Young Kim; Eun Hye Lee; Hoi Soo Yoon
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.